Clinical Trial Update: Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome [NA]

View source ↗

Summary

Completed clinical trial evaluating neomycin with rifaximin for methane-positive constipation-predominant irritable bowel syndrome; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation-predominant Irritable Bowel Syndrome
• Irritable Bowel Syndrome

Drugs mentioned

• Neomycin (neomycin)
• Rifaximin (rifaximin)

Snippet

Sponsor: Mark Pimentel, MD | Conditions: Constipation-predominant Irritable Bowel Syndrome | NA | Status: COMPLETED | Results posted: 2015-08-10